The Sirt1 Activator, SRT1720, Attenuates Cardiac Hypertrophy and Fibrosis in a Rodent Pressure Overload Model

被引：0
|
作者：
Ford, Christopher M.
Civitarese, Robert A.
Bugyei-Twum, Antoinette
Mitchell, Melissa
Desjardins, Jean-Francois
Thai, Kern
Abadeh, Armin
Zhang, Yanling
Switzer, Jennifer
Advani, Andrew
Gilbert, Richard E.
Connelly, Kim A.
机构：
来源：
CIRCULATION | 2014年 / 130卷
关键词：
Hypertension; Heart failure; Hemodynamics; Hypertrophy; Heart disease;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
19029
引用
收藏
页数：4
相关论文
共 26 条
  • [1] Sirt1 Mediates Pressure Overload-Induced Cardiac Hypertrophy and Failure in vivo
    Oka, Shinichi
    Alcendor, Ralph
    Zablocki, Daniela
    Zhai, Peiyong
    Yamamoto, Takanobu
    Sadoshima, Junichi
    CIRCULATION, 2011, 124 (21)
  • [2] Esaxerenone Attenuates Cardiac Hypertrophy in a Pressure Overload Model in Mice
    Hayashi, Ou
    Izumiya, Yasuhiro
    Hayashi, Hiroya
    Ishikawa, Hirotoshi
    Fukuda, Daiju
    INTERNATIONAL HEART JOURNAL, 2025, 66 (01) : 137 - 143
  • [3] SIRT1 activation attenuates diastolic dysfunction by reducing cardiac fibrosis in a model of anthracycline cardiomyopathy
    Cappetta, Donato
    Esposito, Grazia
    Piegari, Elena
    Russo, Rosa
    Ciuffreda, Loreta Pia
    Rivellino, Alessia
    Berrino, Liberato
    Rossi, Francesco
    De Angelis, Antonella
    Urbanek, Konrad
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 205 : 99 - 110
  • [4] Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload
    Beetz, Nadine
    Rommel, Carolin
    Schnick, Tilman
    Neumann, Elena
    Lother, Achim
    Monroy-Ordonez, Elsa Beatriz
    Zeeb, Martin
    Preissl, Sebastian
    Gilsbach, Ralf
    Melchior-Becker, Ariane
    Rylski, Bartosz
    Stoll, Monika
    Schaefer, Liliana
    Beyersdorf, Friedhelm
    Stiller, Brigitte
    Hein, Lutz
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2016, 101 : 145 - 155
  • [5] Astaxanthin attenuated pressure overload-induced cardiac dysfunction and myocardial fibrosis: Partially by activating SIRT1
    Zhang, Jun
    Wang, Quan-Zhen
    Zhao, Shao-Hua
    Ji, Xiang
    Qiu, Jie
    Wang, Jian
    Zhou, Yi
    Cai, Qian
    Zhang, Jie
    Gao, Hai-Qing
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2017, 1861 (07): : 1715 - 1728
  • [6] Knockout of β1- and β2-adrenoceptors attenuates pressure overload-induced cardiac hypertrophy and fibrosis
    Kiriazis, H.
    Wang, K.
    Xu, Q.
    Gao, X-M
    Ming, Z.
    Su, Y.
    Moore, X-L
    Lambert, G.
    Gibbs, M. E.
    Dart, A. M.
    Du, X-J
    BRITISH JOURNAL OF PHARMACOLOGY, 2008, 153 (04) : 684 - 692
  • [7] Peroxiredoxin-1 ameliorates pressure overload-induced cardiac hypertrophy and fibrosis
    Tang, Chaoliang
    Yin, Guobing
    Huang, Chunxia
    Wang, Hongtao
    Gao, Jie
    Luo, Jianfeng
    Zhang, Zhetao
    Wang, Jiawu
    Hong, Junmou
    Chai, Xiaoqing
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 129
  • [8] RIP2 deficiency attenuates cardiac hypertrophy, inflammation and fibrosis in pressure overload induced mice
    Zhao, Cui-Hua
    Ma, Xiang
    Guo, Hong-Yu
    Li, Peng
    Liu, Hong-Yang
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 493 (02) : 1151 - 1158
  • [9] TRPA1 inhibition ameliorates pressure overload-induced cardiac hypertrophy and fibrosis in mice
    Wang, Zhen
    Xu, Yao
    Wang, Menglong
    Ye, Jing
    Liu, Jianfang
    Jiang, Huimin
    Ye, Di
    Wan, Jun
    EBIOMEDICINE, 2018, 36 : 54 - 62
  • [10] Follistatin-like 1 Protein Attenuates Cardiac Hypertrophy Following Pressure Overload.
    Shimano, Masayuki
    Ouchi, Noriyuki
    Murohara, Toyoaki
    Walsh, Kenneth
    CIRCULATION, 2010, 122 (21)
123